Results 101 to 110 of about 15,884 (195)

Entecavir-Associated Thrombocytopenia: A Case Report and Review of the Pathophysiology, Diagnosis, and Treatment of a Rare but Reversible Cause of Thrombocytopenia

Case Reports in Hematology, 2019
Drug-associated thrombocytopenia is often unrecognized. We report a 76-year-old female with lymphoma who presented with easy bruising and oral bleeding. She had undergone screening for hepatitis B virus (HBV) prior to starting rituximab and was found to ...
Binoy Yohannan, Dai Chu N. Luu, Mark Feldman   +2 more
doaj   +1 more source

Evaluasi Terapi Pada Pasien Hepatitis B Di Rsup Dr. Sardjito YOGYAKARTA [PDF]

, 2017
Chronic infection with hepatitis B virus (HBV) is a serious problem because of its spread around the world is quite high (350 million people infected with HBV). This study aims to describe fitness, therapeutic results and the effect of compliance against
Trisnaningtyas, R. W. (Rahmannisa)
core  

Entecavir [PDF]

Reactions Weekly, 2020
  +4 more sources

Prospects for Controlling Hepatitis B Globally

Pathogens
Infection with the hepatitis B virus (HBV) is highly prevalent globally. Over 250 million people suffer from chronic hepatitis B, and more than 800,000 patients die each year due to hepatitis B complications, including liver cancer.
Vicente Soriano, Víctor Moreno-Torres, Ana Treviño, Fernando de Jesús, Octavio Corral, Carmen de Mendoza   +5 more
doaj   +1 more source

Experience of entecavir in renal graft recipients with chronic hepatitis B

Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2011
Aim of investigation. To estimate efficacy and safety of entecavir (ETV) in chronic hepatitis B (CHB) at renal graft recipients (RGR).Material and methods.
M. L. Zubkin, Ye. P. Sel'kova, F. K. Kokoyeva, T. A. Semenenko, V. I. Chervinko, A. N. Kolomoyets, E. M. Balakirev, A. V. Frolov, T. P. Nekrasova   +8 more
doaj  

Impacto de la utilización de hígados de donantes anti-HBc positivo en pacientes trasplantados por hepatitis B [PDF]

, 2011
El nostre objectiu és avaluar l'impacte de la utilització de fetges de donants anti-HBc positius en pacients trasplantats per hepatitis B, els quals van ser revisats de manera retrospectiva.
García Eliz, Marcia, Prieto Castillo, Martín, Universitat Autònoma de Barcelona. Departament de Medicina, Universitat Autònoma de Barcelona. Facultat de Medicina, Vargas Blasco, Víctor   +4 more
core  

Serum miR-146a and miR-155 as Predictors of Virological Control After Entecavir Withdrawal in HBeAg-Positive Chronic Hepatitis B Patients

The Turkish Journal of Gastroenterology
Background/Aims: Distinct virological relapse (VR) has occurred after stopping the use of nucleos(t)ide analogues treatment in patients with chronic hepatitis B (CHB) who are positive for Hepatitis B e antigen (HBeAg).
Ming Li Xu, Li Huan Wang
doaj   +1 more source

Universitat i empresa química: un diàleg necessari entre dos mons complementaris [PDF]

, 2015
Un diàleg fluid entre les universitats i altres centres de recerca de Catalunya amb el teixit empresarial és, avui dia, una exigència social ineludible.
Ariza, Xavier, Bartra, Martí, Berenguer, Ramon, Farràs i Farràs, Jaume, Garcia, Jordi, López, Blanca, Solsona, Joan Gabriel, Tolrà, Roser, Velasco, Xavier   +8 more
core  

Erratum to 'The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meeting' [J. Clin. Virol. 41 (4) 2008 243-254] [PDF]

, 2008
Barclay, Stephen, Benhamou, Yves, Cameron, Sheila, Carman, William, Hayes, Peter C, Mills, Peter R, Mutimer, David, Pol, Stanislas   +7 more
core   +1 more source

Combination Therapy for Chronic Hepatitis B: Current Indications [PDF]

, 2011
Navin Paul, Steven-Huy Han
core   +1 more source